{"organizations": [], "uuid": "f47d3e462d358678cb46a6187cfbb7442706ea9b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-teva-canada-announces-launch-of-te/brief-teva-canada-announces-launch-of-teva-cyclosporine-ophthalmic-emulsion-idUSASC0A1HA", "country": "US", "domain_rank": 408, "title": "BRIEF-Teva Canada Announces Launch Of Teva-Cyclosporine Ophthalmic Emulsion", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-10T16:22:00.000+03:00", "replies_count": 0, "uuid": "f47d3e462d358678cb46a6187cfbb7442706ea9b"}, "author": "", "url": "https://www.reuters.com/article/brief-teva-canada-announces-launch-of-te/brief-teva-canada-announces-launch-of-teva-cyclosporine-ophthalmic-emulsion-idUSASC0A1HA", "ord_in_thread": 0, "title": "BRIEF-Teva Canada Announces Launch Of Teva-Cyclosporine Ophthalmic Emulsion", "locations": [], "entities": {"persons": [], "locations": [{"name": "canada", "sentiment": "none"}, {"name": "canada", "sentiment": "none"}], "organizations": [{"name": "brief-teva canada announces launch of teva-cyclospor", "sentiment": "negative"}, {"name": "ine ophthalmic emulsion reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "teva pharmaceutical industries ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 10, 2018 / 1:23 PM / Updated 29 minutes ago BRIEF-Teva Canada Announces Launch Of Teva-Cyclosporine Ophthalmic Emulsion Reuters Staff 1 Min Read\nMay 10 (Reuters) - Teva Pharmaceutical Industries Ltd :\n* TEVA CANADA ANNOUNCES THE LAUNCH OF TEVA-CYCLOSPORINE® OPHTHALMIC EMULSION, THE FIRST GENERIC VERSION OF RESTASIS® IN CANADA FOR THE TREATMENT OF DRY EYE DISEASE\n* TEVA CANADA LIMITED - LAUNCH OF TEVA-CYCLOSPORINE OPHTHALMIC EMULSION, 0.05% W/V IN CANADA Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)", "external_links": [], "published": "2018-05-10T16:22:00.000+03:00", "crawled": "2018-05-10T16:41:44.008+03:00", "highlightTitle": ""}